Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A infiltrating urothelial carcinoma that involves the renal pelvis.
Biomarker and diagnostic research for infiltrating renal pelvis transitional cell carcinoma has been reported in the published literature.
No clinical trials have been registered for infiltrating renal pelvis transitional cell carcinoma.
6 publications have been identified in PubMed for infiltrating renal pelvis transitional cell carcinoma. Research spans Case Report / Case Series (67%), Diagnostic / Biomarker (17%), and Clinical Trial Publication (17%).
Zhu X (2025). [PMID: 39906765](https://pubmed.ncbi.nlm.nih.gov/39906765/). *Urology case reports*. [Case Report / Case Series]
Ghosh S (2025). [PMID: 39537307](https://pubmed.ncbi.nlm.nih.gov/39537307/). *The Urologic clinics of North America*. [Diagnostic / Biomarker]
Chaloupková L (2025). [PMID: 41553813](https://pubmed.ncbi.nlm.nih.gov/41553813/). *Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti*. [Case Report / Case Series]
Houédé N (2025). [PMID: 39951246](https://pubmed.ncbi.nlm.nih.gov/39951246/). *Journal of clinical oncology : official journal of the American Society of Clinical Oncology*. [Clinical Trial Publication]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 1:11 PM UTC
Nueva Espana-Perez MV (2024). [PMID: 39036214](https://pubmed.ncbi.nlm.nih.gov/39036214/). *Cureus*. [Case Report / Case Series]